SenesTech to Release Q1 2026 Financial Results and Host Conference Call

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: May 07 2026

0mins

SNES-2.2%

Explore Agentic TradingLet AI Trade for You

Source: Newsfilter

Financial Report Schedule: SenesTech will release its Q1 2026 financial results after market close on May 12, 2026, reflecting the company's ongoing commitment to transparency in animal pest management.
Conference Call Timing: On the same day, SenesTech will hold a conference call at 5:00 PM ET to discuss the financial results in detail and engage with investors, thereby enhancing investor confidence.
Live Webcast Information: Interested parties can access the conference call via a live webcast available on the company's Investor Relations page, ensuring broad participation and information dissemination to boost corporate transparency.
Company Mission and Vision: SenesTech is dedicated to improving environments through humane birth control products, reducing reliance on traditional poisons, and promoting sustainability, showcasing its leadership position in the industry.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy SNES?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on SNES

Wall Street analysts forecast SNES stock price to rise

1 Analyst Rating

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 1.820

Low

10.00

Averages

10.00

High

10.00

Current: 1.820

Low

10.00

Averages

10.00

High

10.00

No data

About SNES

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

SenesTech to Participate in 2026 Investor Conference

May 19 2026PRnewswire

Webcast Schedule: SenesTech will host a webcast on May 28, 2026, at 2:30 p.m. ET, accessible via the conference homepage, enhancing investor engagement and transparency.
One-on-One Meeting Opportunities: Management will participate in virtual one-on-one meetings during the event, allowing investors to arrange discussions with the company, aimed at strengthening relationships and driving funding opportunities.
Commitment to Product Innovation: SenesTech focuses on managing animal pest populations through fertility control, with its Evolve product effectively integrated into pest management programs, reducing reliance on traditional poisons and reflecting the company's strategic commitment to sustainability.
Forward-Looking Statement Caution: The press release includes forward-looking statements regarding market acceptance, financial performance, and product commercialization risks, advising investors to consider potential uncertainties for informed investment decisions.

SenesTech to Participate in 2026 Investor Conference

May 19 2026Newsfilter

Investor Conference Participation: SenesTech will participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026, with a webcast presentation scheduled for 2:30 PM ET, aimed at enhancing the company's visibility among investors and attracting potential investment.
One-on-One Meeting Opportunities: Management will engage in virtual one-on-one meetings throughout the event, allowing investors to arrange discussions with the team, which helps strengthen investor relations and delve into the company's strategies and future plans.
Commitment to Product Innovation: SenesTech focuses on managing animal pest populations through fertility control, with products like Evolve rodent birth control designed to reduce reliance on traditional poisons, thereby enhancing pest management effectiveness and promoting sustainability and environmental health.
Forward-Looking Statement Risks: The press release includes forward-looking statements regarding market acceptance, financial performance, and product commercialization, indicating that the company faces uncertainties in achieving growth objectives, which investors should carefully consider when assessing potential risks.

SenesTech Q1 2026 Earnings Call Insights

May 13 2026seekingalpha

Direct-to-Consumer Growth: SenesTech reported a 42% increase in direct-to-consumer revenue for Q1, reaching a record $194,000, indicating strong performance in this core growth engine and expected to further drive overall revenue growth.
E-commerce Sales Surge: Following the direct management of its Amazon account, April e-commerce sales soared 163% to $146,000, demonstrating early success in the company's e-commerce transformation and potential for continued market share expansion.
Strong Financial Performance: Total revenue for Q1 was $493,000, despite approximately $443,000 in one-time expenses, with gross margin improving to 68.6%, reflecting enhanced cost control and profitability, which strengthens future financial flexibility.
Strategic Execution Priority: Management emphasized that “commercial execution at scale” is the current central priority, with plans to expand the Evolve brand and launch new products, showcasing the company's proactive positioning in the competitive landscape and confidence in future growth.

SenesTech Reports Strong E-Commerce Transition Results in Q1 2026

May 12 2026PRnewswire

E-Commerce Transition Success: Under the leadership of new CEO Michael Edell, SenesTech's direct-to-consumer revenue surged 42% to a record $194,000 in Q1, reflecting strong market demand and growth potential as the company transitions to in-house Amazon management.
Record Gross Margin: The gross margin reached a historic high of 68.6% in Q1, indicating significant progress in operational optimization and cost control, thereby laying a solid foundation for sustainable future growth.
Accelerating Subscription Sales: With direct control over e-commerce channels, subscription sales have continued to accelerate, breaking previous revenue records and demonstrating increasing consumer acceptance of non-toxic rodent management solutions, enhancing the company's competitive position.
Strategic Investment Focus: Edell emphasized that by improving customer experience and conversion rates, SenesTech is building a more predictable recurring revenue model aimed at achieving sustainable business growth in the long term, aligning with the company's strategic vision for future markets.